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Feline immunodeficiency virus (FIV) infects numerous wild and domestic feline species and is closely related
to human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV). Species-specific strains of
FIV have been described for domestic cat (Felis catus), puma (Puma concolor), lion (Panthera leo), leopard
(Panthera pardus), and Pallas’ cat (Otocolobus manul). Here, we employ a three-antigen Western blot screening
(domestic cat, puma, and lion FIV antigens) and PCR analysis to survey worldwide prevalence, distribution,
and genomic differentiation of FIV based on 3,055 specimens from 35 Felidae and 3 Hyaenidae species. Although
FIV infects a wide variety of host species, it is confirmed to be endemic in free-ranging populations of nine
Felidae and one Hyaenidae species. These include the large African carnivores (lion, leopard, cheetah, and
spotted hyena), where FIV is widely distributed in multiple populations; most of the South American felids
(puma, jaguar, ocelot, margay, Geoffroy’s cat, and tigrina), which maintain a lower FIV-positive level through-
out their range; and two Asian species, the Pallas’ cat, which has a species-specific strain of FIV, and the
leopard cat, which has a domestic cat FIV strain in one population. Phylogenetic analysis of FIV proviral
sequence demonstrates that most species for which FIV is endemic harbor monophyletic, genetically distinct
species-specific FIV strains, suggesting that FIV transfer between cat species has occurred in the past but is
quite infrequent today.
Feline immunodeficiency virus (FIV) is a lentivirus that in-
fects both wild and domestic felid species and is closely related
to human immunodeficiency virus (HIV) and simian immuno-
deficiency virus (SIV) (9, 11, 21, 26). Species-specific strains of
FIV have been described for domestic cat (Felis catus), puma
(Puma concolor), lion (Panthera leo), leopard (Panthera par-
dus), and Pallas’ cat (Otocolobus manul) (termed FIV-Fca,
FIV-Pco, FIV-Ple, FIV-Ppa, and FIV-Oma, respectively) (3, 8,
10, 11, 17, 22, 29). In domestic cats, viral infection results in an
AIDS-like pathology typified by a period of latency followed by
CD4 depletion, immune suppression, and a host of subsequent
secondary infections (37). Because of its striking similarity to
the pattern of disease progression observed with HIV infection
in humans, FIV-Fca offers a promising model system for un-
derstanding many clinical aspects of retroviral immunodefi-
ciency syndrome (37). Variant strains of FIV have been found
with several of the nondomestic species of the cat family,
Felidae, yet there has been no verifiable disease association for
any of these felid species to date (3, 8–10, 17, 20, 24). Whether
nondomestic cat FIV strains are less virulent, less pathogenic,
or, alternatively, spreading in species with genetic adaptations
that confer efficient immunological defenses is unclear. None-
theless, the widespread FIV occurrence among Felidae species
provides some productive epidemiological and evolutionary
parallels to human and simian lentiviruses.
Serological (Western blot) evidence of FIV infection has so
far been documented for 18 of 37 nondomestic feline species
worldwide, and FIV strains infecting 4 of these species have
been at least partially sequenced and characterized in molec-
ular terms (3, 6, 7, 9, 10, 14, 18, 19, 20, 21, 23, 38). However,
population-wide genetic data are available for only two non-
domestic species, the puma (5, 10) and the lion (8, 35), and
much of the previous evidence for infection in non-African
species comes from captive animal sera that cross-react with
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domestic cat FIV-Fca, which is genetically and antigenically
divergent from exotic cat strains of FIV (3, 8, 10).
Here, we employ a three-antigen Western blot screening
(cat, puma, and lion FIV antigens) and a multigene PCR
amplification of FIV genes to estimate worldwide prevalence,
distribution, and genomic differentiation of FIV strains among
the Felidae family and its closest relative, the Hyaenidae. The
maximal sensitivity of the three-target immunological screen-
ing combined with the specificity of the PCR detection meth-
ods provides a comprehensive epidemiological and phyloge-
netic view of the present disposition and ancestral history of
FIV.
We conclude from this survey that while FIV infects a wide
variety of host species, it is currently endemic in few free-
ranging populations, including (i) the large African carnivores,
where FIV is widely distributed in multiple populations; (ii)
most of the South American felids, which maintain a lower
FIV-positive level throughout their range; and (iii) two Asian
species, Pallas’ cat, which has a species-specific strain of FIV,
and Leopard cat, which has been shown to be susceptible to
domestic cat FIV (20). Monophyly of FIV proviral sequence
for most species suggests that FIV transfer between cat species
is an infrequent event.
MATERIALS AND METHODS
Samples for seroprevalence and DNA analysis. Blood samples were collected
from free-ranging and captive animals from around the world. Blood separation
via centrifugation was performed either on site or upon shipment to the Labo-
ratory of Genomic Diversity, NCI-Frederick. Blood products (serum, plasma,
white blood cells, blood clots) were frozen at 70°C until use. Serum or plasma
samples were used directly for Western blot analysis. DNA was extracted from
whole blood or pelleted white blood cells.
Western blot analysis of serum and plasma samples. A three-antigen chemi-
luminescence Western blot screening was performed with 1,195 serum or plasma
samples as follows. Viral isolates from domestic cats, pumas, and lions were
grown in cell culture, and viral proteins were isolated as previously described
(36). Briefly, tissue culture supernatant from virus-infected cells was centrifuged
at 1,000 rpm in a Beckman GPR centrifuge for 10 min at 5°C to remove cellular
material. The supernatant was then centrifuged at 27,000 rpm at 4°C for 2 h in
a Beckman L-70 ultracentrifuge using an SW28 rotor. The supernatant was
discarded, and the pellet was resuspended in a volume of one-twentieth of the
original culture supernatant. The protein content was assayed using a Bio-Rad
protein assay.
Twenty milligrams of viral protein was run on a 4 to 20% Tris-glycine gel and
transferred to a polyvinylidene difluoride (Bio-Rad) membrane in a Novex Mini-
Cell unit as suggested by manufacturer (Invitrogen). Four-millimeter-wide strips
were exposed overnight to a 1:200 dilution of serum or plasma with 5% pow-
dered milk in Tween buffer (0.2 M Tris, 0.1 M NaCl, 0.1% Tween 20 [pH 8.0]).
A series of six 10-min washes were performed with Tween buffer and then
samples were labeled with goat anti-cat horseradish peroxidase-conjugated an-
tibody (KPL laboratories) at a 1:2,000 dilution in 5% powdered milk in Tween
buffer. Six 10-min washes were performed, and strips were incubated in ECL
Western blotting detection reagents (Amersham Biosciences) for 2 min and then
exposed to Lumi-Film chemiluminescent detection film (Boehringer Mann-
heim). Film was visualized and scored manually as positive, indeterminate, or
negative based on the presence and intensity of antibody binding to the p24 gag
capsid protein. An additional 1,870 samples were screened for FIV-reactive
antibodies as previously described (7).
PCR amplification of proviral DNA. Genomic DNA was isolated from white
blood cells of 435 seropositive (273), seroindeterminate (108), or seronegative
(54) animals using Proteinase K digestion followed by a standard phenol-chlo-
roform extraction. Nested and nonnested PCR using primers designed from the
conserved reverse transcriptase region of pol, the RNase region of pol, and the
p26 region of gag were used to amplify the FIV sequences (Fig. 1). All primers
were designed from the GenBank sequences of FIV-Fca (accession number
M25381 and U11820), FIV-Pco (accession number U03982), and FIV-Oma
(accession number U56928). All first-round PCRs were performed using 100 ng
of genomic DNA in a 50-l reaction with 50 mM KCl, 10 mM Tris-HCl (pH 8.3),
2.5 mM MgCl2, 0.25 mM (each) of dATP, dCTP, dGTP, and dTTP, 2 mM of
each primer, and 2 units of AmpliTaq DNA polymerase from PE Applied
Biosystems. PCR cycling conditions were as follows: 3 min at 94°C; 45 cycles of
15 s at 94°, 30 s at 52°C or 50°C, and 45 s at 72°C; and a final extension of 10 min
at 72°C. Second-round PCRs were done under the same conditions, with 1 l of
product from the first-round reaction used as template. These amplifications
were performed with a Perkin-Elmer 9700 thermocycler and visualized with a 1%
agarose gel. Samples were also run with a touchdown protocol with temperatures
from 58°C to 48°C. All other cycling conditions were the same as those described
above. PCR products were sequenced using standard ABI BigDye terminator
reactions.
Phylogenetic analysis. Representative nucleotide species for each species from
pol-RT were compiled and aligned for subsequent phylogenetic analysis using
ClustalX (34) and verified visually. Phylogenetic reconstructions were performed
using PAUP version 4.0 (32) and included minimum evolution estimated by
neighbor joining (ME), maximum parsimony (MP), and maximum likelihood
(ML). ModelTest (28) was used to estimate the optimal model of sequence
FIG. 1. A schematic representing the positions of the primers used for PCR confirmation on the FIV genome. The “5 position” reflects the
position with respect to FIV-Fca Petaluma strain (accession number 323933). Single round and nested primer sets that produced FIV sequence
from at least one animal are described. LTR, long terminal repeat; RT, reverse transcriptase; IN, integrase.
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evolution, the general time-reversible model of substitution corrected for among-
site rate variation (gamma distribution), and a proportion of invariant sites. ME
and ML trees were constructed using this model (see legend for Fig. 4a), with
starting trees obtained by neighbor joining followed by a tree bisection-recon-
nection branch swapping algorithm during a heuristic search for the optimal tree.
Maximum parsimony analysis employed a heuristic search of starting trees ob-
tained by stepwise addition followed by tree bisection-reconnection branch swap-
ping. Bootstrap analysis included 1,000 iterations for ME and MP and 100
iterations for ML. In addition, Bayesian posterior probabilities were calculated
using a Markov chain Monte Carlo sampling approach with MrBayes 3.0b4 (16).
Starting trees were random, four simultaneous Markov chains were run for one
million generations, burn-in values were set at 45,000 generations, and trees were
sampled every 20 generations.
Additional analyses were conducted on the pol gene sequences translated into
amino acids. Phylogenetic trees were derived from the amino acid residue data
using two algorithms of distance-based and maximum likelihood. The genetic
distance measure of the PAM-Dayhoff model of amino acid substitution (12) was
used to construct a neighbor-joining tree using the PHYLIP program, version 3.5
(13). Bootstrap analyses consisting of 1,000 repetitions were conducted for the
distance-based analysis using PHYLIP. The maximum likelihood analyses of
amino acids and relative bootstrap values used the PAM-Dayhoff model of
substitution (12) as implemented by the ProtML subroutine of the MOLPHY
program, version 2.3 (1).
Nucleotide sequence accession numbers. The novel nucleotide sequences in
this data set have been deposited in the GenBank database under the following
accession numbers: for FIV-Ple, accession numbers AY878208 to AY878235; for
FIV-Ccr, accession numbers AY878196 to AY878200; for FIV-Aju, accession
numbers AY878201 to AY878203; for FIV-Ppa, accession numbers AY878204 to
AY878207; for FIV-Pco, accession numbers AY878236 to AY878237; for FIV-
Oma, accession numbers AY878238 to AY878241; for FIV-Lpa, accession num-
ber AY878194; for FIV-Hya, accession number AY878195; and for FIV-Pun,
accession number AY878242. Additional nucleotide sequences used in the phy-
logenetic analyses were obtained using BLAST (2) and BLAST 2 sequences (33)
and have the following accession numbers: U53727 (Pco-163), U53722 (Pco-
144), U53729 (Pco-245), U53718 (Pco-117), U53755 (Pco-733), U53751 (Pco-
590), U53725 (Pco-145), U53756 (Pco-28), U53748 (Pco-336), M66437
(SIVagm), AY159322 (SIVmnd), AY159321 (SIVdrl), AF447763 (SIVcpz),
AF334679 (SIVsm), AF301156 (SIVcol), AF131870 (SIVsu), AF075269 (SIVl-
hoest), AB100245 (HIV type 2 [HIV-2]), AF004885 (HIV-1 subtype A [HIV-1
A]), K03455 (HIV-1 B), U52953 (HIV-1 C), K03454 (HIV-1 D), AF077336
(HIV-1 F), AF084936 (HIV-1 G), AF190127 (HIV-1 H), AF082394 (HIV-1 J),
AJ249235 (HIV-1 K), AJ271370 (HIV-1 N), L20587 (HIV-1 O), AF24739
(equine infectious anemia virus), M32690 (bovine immunodeficiency virus),
AF479638 (ovine), AY101611 (visna), and M33677 (caprine arthritis-encephali-
tis virus).
RESULTS
In this study, 1,195 animals from 38 species were tested by
Western blotting (Table 1; Fig. 2) for the presence of antibod-
ies that would react to a panel of three different FIV virus
isolates, FIV-Fca from the domestic cat, FIV-Ple from the lion,
and FIV-Pco from the puma. The three viruses, FIV-Fca, FIV-
Ple, and FIV-Pco, are genetically distant from each other and
have the potential to detect antibody responses to a wide
variety of viral epitopes (9). Thus, a virus closely related to
FIV-Pco might be more likely to elicit an antibody response
that was detectable with FIV-Pco antigen than with FIV-Fca
antigen. Samples from 248 animals from 9 species showed
antibody reactions to all three viral antigens, samples from an
additional 184 animals from 22 species demonstrated antibody
responses to only one or two of the FIV viruses, and samples
from 753 animals were seronegative (Table 1).
When tested directly, species-specific viruses (i.e., FIV-Ple
for lion samples and FIV-Pco for puma samples) were more
sensitive than either of the nonspecific viruses (species speci-
ficity is demonstrated for lion samples tested against FIV-Ple,
FIV-Pco, and FIV-Fca in Fig. 2). Of the 45 lion sera that
showed FIV cross-reactive antibodies to only one or two of the
three viruses, 26 reacted to FIV-Ple only, 12 reacted to FIV-
Ple plus one other virus, and 6 reacted to FIV-Pco or FIV-Fca
and not to FIV-Ple. Similar results, where homologous FIV
antigens were most effective at detecting antibody response,
were seen with pumas. Of the 33 partial positive puma samples,
11 were reactive to FIV-Pco only, 17 to FIV-Pco plus one other
virus, and only 5 to FIV-Ple or FIV-Fca but not to FIV-Pco.
While the use of FIV-Pco, FIV-Ple, and FIV-Fca antigens in
the Western blot screening resulted in many more samples
with FIV cross-reactive antibodies than one virus alone, the
significance of these partial positives is, in many cases, unclear.
Samples that produced strong positive results against one FIV
strain usually reacted equally well to the other two strains.
Therefore, many of the partial positives were also relatively
weak signals, resulting in an “indeterminate” designation. In-
determinate signals were often, though not always, negative by
PCR screenings (Table 1), suggesting that many were false
positives, although some may be positive for genetically diver-
gent (from the PCR primers) variants.
A summation of results from the three-antigen Western blot
screening using combined captive-born, wild-born, and/or free-
ranging animals from 36 species is presented in Table 1.
Twelve of the tested species, namely, the African golden cat,
the black footed cat, three hyena species (brown, spotted, and
striped), the caracal, the sand cat, three lynx species (Cana-
dian, European, and Iberian), the kodkod, and the bay cat, are
unrepresented in the FIV literature. Spotted and striped hye-
nas were the only newly tested species with convincing FIV
antibody responses, although samples sizes for most of these
species were too small for any negative conclusion. Indetermi-
nate FIV antibody reactions were seen for nine species where
no FIV reactivity has previously been reported; these were the
black footed cat, sand cat, Canadian lynx, Iberian lynx, Pampas
cat, Asian golden cat, European wild cat, jungle cat, and mar-
bled cat.
The three-antigen FIV Western blot results were compared
with previously published and new data from Western blotting
using a single viral antigen, FIV-Fca (Table 1, combined re-
sults columns) (6–11, 21). In populations that were screened
with the three-antigen Western blot screening and by FIV-Fca
alone, slightly more FIV-reactive samples were seen with the
three-antigen screening. However, strong seropositive results
were highly concordant for the three- and one-antigen screen-
ings. For example, the cheetahs in the Serengeti had 22%
strong positives with the three-antigen screening (n  9) and
24% strong positives with FIV-Fca (n  41). Florida panthers
(pumas) had 23% strong positives with three antigens (n  30)
and 20% strong positives with FIV-Fca alone (n  79), and
Tanzania lions had 83% strong positives with three antigens
(n  145) and 86% strong positives with FIV-Fca alone
(n  269).
The frequency of weak (indeterminate) reactions increased
when the three-antigen screening was used. For example, 22%
of Serengeti cheetahs were indeterminate with the three-anti-
gen test (weak signal against at least one antigen) while 5%
were indeterminate (weak positive) with FIV-Fca alone; 40%
of Florida panthers were indeterminate with three antigens,
and 5% were indeterminate with FIV-Fca alone. In contrast,
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7% of Serengeti lions were indeterminate with three antigens,
and 8% were indeterminate with FIV-Fca alone.
Because the results from strong positives are similar with
both methods, results from the 1,195 animals screened with all
three antigens have been combined with results from the 1,866
animals screened with FIV-Fca alone for a total of 3,055 ani-
mals from 38 species (Table 1, combined results columns). Of
these, 684 animals were Western blot positive for FIV, and 260
were indeterminate, meaning that between 22% and 31% of
the animals tested have antibodies to FIV (Table 1). A major-
ity of the positive results come from lions (502) and pumas
(94). However, positive signals were seen for some individuals
from 17 other species, and almost all species demonstrated
some level of FIV reactivity, suggesting that FIV may be cir-
culating in several additional feline host species. All individual
animals of nine of the species screened (bay cat, rusty spotted
cat, African golden cat, brown hyena, kodkod, serval, Euro-
pean lynx, caracal, and leopard cat) were negative (Table 1).
FIG. 2. Western blots showing differential antibody reactivity to the three FIV viral antigens. Lanes 14 and 15 contain serum from a known
FIV-positive (Western blotting and PCR) and a known FIV-negative lion, respectively. Lanes 1 to 5 contain serum from seropositive and
seroindeterminate hyenas. Lanes 6 to 10 contain serum from leopards that have strong antibody response to FIV-Ple and variable reactions to
FIV-Fca and FIV-Pco. Lanes 11 to 13 contain serum from lions that have strong antibody responses to FIV-Ple and weak or negative antibody
responses to the other two antigens.
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However, with the exception of the caracal and leopard cat,
there were very few samples from these species.
PCR amplification of lymphocyte-derived DNA from 435
animals representing a subset of seropositive, seroindetermi-
nate, and seronegative individuals (Table 1, PCR verification
results) was attempted using several primer combinations
within gag, pol-RT, and pol-RNase (Fig. 1) (35). Where avail-
able, samples from free-ranging and wild-born individuals were
used. The PCR success rate (i.e., the percentage of individual
animals from which FIV sequence was obtained for at least
one gene region) was 69% (188/273) for seropositive samples
and 21% (23/108) for seroindeterminates; all 54 seronegative
samples were PCR negative at all gene regions. Most PCR-
positive samples did not amplify at all gene regions, and the
highest success rate was within the most conserved gene re-
gion, pol-RT. All products were sequenced to validate their
homologies to FIV.
Table 2 presents the Western blot data (positive, indetermi-
nate, and negatives for each species) separated into three cat-
egories of specimens, those collected from free-ranging ani-
mals, from animals held in captivity but born in the wild, and
from captive-born animals. These data demonstrate a much
higher incidence of FIV in free-ranging animals (40 to 50%)
than in captive ones (7 to 13%). Based on positive Western
blot results from free-ranging and wild-born individuals, nine
species, namely, the cheetah, leopard, lion, spotted hyena,
striped hyena, margay, ocelot, puma, and Pallas’ cat, have FIV
circulating in the wild. Indeterminate Western blot results are
seen for free-ranging and wild-born individuals from an addi-
tional five species, namely, bobcat, the Geoffroy’s cat, jaguar,
Iberian lynx, and tiger. Finally, several species harbor FIV in
captivity but not in free-ranging populations; these are the
African wild cat, sand cat, flat-headed cat, tiger, and Asian
leopard (Table 2). Captive-born animals have been excluded
from the remainder of the seroprevalence analyses.
Species with the highest prevalence of FIV-positive animals
are found in Africa (Fig. 3a). For the African lion, 68% of the
animals are seropositive and an additional 6% are seroinde-
terminate, giving an overall prevalence of 68 to 74%. FIV is
endemic in the leopard (26 to 46%) and in the striped and
spotted hyena (23 to 47% and 14 to 24%, respectively). Al-
though the cheetah has very low overall prevalence, 6 to 8%,
this result reflects a geographic sampling bias, as FIV is present
in high frequency (40%) in some cheetah populations (Tanza-
nia, n 17) and absent (0 to 2%) in others (Namibia, n 321),
and the majority of our samples come from the FIV-negative
population. In contrast, FIV-reactive antibodies have not been
found in the smaller African cats (serval, caracal, and African
wild cat) or in the brown hyena, although few (1 to 14) samples
from wild-caught animals (Table 2) were available for these
species. No samples from wild-born or free-ranging animals
were tested from the African golden cat, black footed cat, or
sand cat.
In the Americas, FIV is also endemic in several species,
although the overall prevalence is generally lower than in pos-
itive African species (Fig. 3b). The prevalence is highest in
pumas, of which 25% are seropositive and an additional 15%
are seroindeterminate. No seroprevalence was observed for
the Pampas cat (n  10), and only seroindeterminates were
seen with the bobcat (14%; n  44). However, all other species
had low seroprevalence, ranging from 5 to 9% for the Geof-
froy’s cat to 19 to 28% for the jaguarundi (Fig. 3b).
There is a dearth of strong positives from any of the feline
species in Asia and Europe, with the exception of the Pallas’
cats, where seroprevalence is between 33% and 87% (Fig. 3c).
Notably, the lion and the leopard have 0% seroprevalence in
Asia, whereas FIV is endemic in their African counterparts.
However, FIV seroindeterminates are found in seven species
(Asian golden cat, clouded leopard, Iberian lynx, jungle cat,
marbled cat, snow leopard, and tiger) at prevalences ranging
from 6% for the Asian golden cat to 36% for the tiger.
Seropositive status was verified via PCR (for at least one
gene region) from free-ranging cheetahs, leopards, lions, spot-
ted hyenas, and pumas. Seropositive status of one or more
wild-born jaguarundis, margays, ocelots, Pallas’ cats, and snow
leopards and a captive-born tiger were also verified by PCR
(Table 1). Pol-RT sequences from these animals were aligned
with FIV and other lentivirus sequences present in GenBank.
Phylogenetic analysis indicates that the divergent FIV strains
described here are monophyletic relative to other lentiviruses
but align most closely with equine infectious anemia virus and
bovine immunodeficiency virus pol sequences (Fig. 4a). Fur-
ther, the genetic differentiation among FIV-RT sequences is
comparable to the divergence among SIV-HIV isolates (Fig.
4a). The broad FIV divergence can also be seen in an align-
ment of amino acid residues among FIV strains, which dem-
onstrates considerable diversity within and between strains, but
very few species-specific (diagnostic) residues (Fig. 4b). The
majority of changes represent homoplasies (i.e., changes that
appear along more than one branch of the phylogeny) and are
conservative amino acid changes that probably do not change
the function of the molecule. The diagnostic residues, however,
tend to be less conservative and may represent changes that are
positively selected within a lineage. There is also large among
site rate variation, suggesting that some regions of the mole-
cule are under more selective pressure than others.
The lentivirus nucleotide sequences derived from six spotted
hyenas (FIV-Ccr) are monophyletic (bootstrap values of 100/
100/100% for ML/ME/MP, with a posterior probability of 1 for
Bayesian analysis) (Fig. 4a) and specify a sister-taxon associa-
tion with the multispecies FIV clade with strong ML and ME
bootstrap support (bootstrap values of 89/94/65% for ML/ME/
MP) (Fig. 4a). In most nucleotide trees, hyena FIV appears
basal to the FIVs from the felid species (i.e., first within the
FIV lineage to diverge from the common lentiviral ancestor).
Within the Felidae, there is strong bootstrap support for the
monophyly of FIV in domestic cats (FIV-Fca; bootstrap values
of 100/100/100% for ML/ME/MP, with a posterior probability
of 1 for Bayesian analysis) (Fig. 4a) and Pallas’ cats (FIV-Oma;
bootstraps values of 100/100/100% for ML/ME/MP, with a
posterior probability of 1 for Bayesian analysis) (Fig. 4a), and
good bootstrap support for the monophyly of FIV in leopards
(FIV-Ppa; bootstrap values of 87/76/89% for ML/ME/MP, with
a posterior probability of 1 for Bayesian analysis) (Fig. 4a). The
cheetah FIV strain (FIV-Aju) groups with that of the leopards
with good support (bootstrap values of 88/91/59% for ML/ME/
MP, with a posterior probability of 0.99 for Bayesian analysis)
(Fig. 4a). The greatest diversity occurs within the lion FIV
(FIV-Ple) and puma FIV (FIV-Pco), and there are two distinct
monophyletic groups from each of these species. The FIV
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sequences obtained from the ocelot and jaguarundi are genet-
ically distant from any other FIV type, and most likely repre-
sent species-specific strains.
Within the lions, previously described strains A, B, and C are
recapitulated here (8, 35). There is strong support for FIV-Ple
subtype A, found in the Serengeti, Kruger Park, Botswana, and
captive lions; FIV-Ple subtype B, found in the Serengeti, the
Ngorongoro Crater, and Uganda; and FIV-Ple subtype C,
found only in the Serengeti. An additional three monophyletic
subtypes are seen, one from Kenya, one from Botswana, and
one from Kruger Park in South Africa.
These phylogenetic divisions were validated using other
gene regions (pol-RNase or gag) (35) for the FIV-Oma clade,
the FIV-Ppa clade, and the six distinct FIV-Ple clades (sup-
plemental online material). The grouping of FIV-Aju with
FIV-Ppa is also seen with gag, as is the placement of FIV-Oma
basal to the FIV-Aju/FIV-Ppa clade. Additionally, the diver-
gence of ocelot FIV from FIV sequences found in other spe-
cies is confirmed with sequence from a different ocelot in a
pol-RNase phylogeny (supplemental online material). Short
sequences (90 bp) from two margays were identical to each
other and confirmed the presence of FIV but were not useful
for phylogenetic analysis. A pol-RT FIV fragment amplified
from a captive but wild-born snow leopard was shown to clus-
ter in the FIV-Ple subtype A sequences (Fig. 4a). Similarly, a
450-bp FIV gag sequence amplified from a captive-born tiger
grouped with the “Botswana” FIV-Ple clade (supplemental
online material).
Finally, phylogenetic relationships determined using pre-
dicted amino acid sequences (Fig. 4c) recapitulate those seen
with nucleotide sequences, with the following exceptions: (i)
amino acid analysis does not support the basal nature of FIV-
Ccr (hyena), (ii) FIV-Ple (lion) is grouped in one monophyletic
group using amino acid analysis, as opposed to the two sepa-
rate clusters seen with the nucleotide analysis, (iii) FIV-Lpa
(ocelot) and FIV-Hya (jaguarundi) group together with strong
bootstrap support in the amino acid phylogeny but not in the
nucleotide phylogeny, and (iv) FIV amino acid sequences from
African carnivores plus the Pallas cat form a monophyletic
cluster with strong bootstrap support.
DISCUSSION
An abundance of individual specimens (over 3,000 in the
combined screening) from captive-born, wild-born, and free-
ranging animals, the use of diverse FIV antigens, and the
addition of PCR confirmation for FIV infection in many spe-
cies provide the most comprehensive worldwide prevalence
survey to date. Twelve of the species in this survey had no FIV
data previously reported; these were the African golden cat,
the black footed cat, three hyena species (brown, spotted, and
striped), the caracal, the sand cat, three lynx species (Cana-
dian, European, and Iberian), the kodkod, and the bay cat.
While many of these species are quite rare and there is some
difficulty in obtaining samples even from captive individuals,
resulting in small sample sizes for the small African and Asian
FIG. 3. Prevalence and distribution of FIV seroreactivity in free-ranging and captive but wild-born animals. The dark portion of the bar
represents seropositives and the white portion represents seroindeterminates, giving conservative and liberal estimates of total seroprevalence of
FIV. The number of animals tested for each species is given in parentheses. A black star indicates that PCR verification has been obtained from
at least one free-ranging individual for that species. A white star indicates that PCR verification has been obtained from at least one captive but
wild-born individual for that species. (a) Percent seroreactivity in African carnivores (excluding African golden cat, sand cat, and black footed cat,
for which there were no wild-born samples). (b) Percent seroreactivity in American felids (excluding kodkod and Canadian lynx, for which there
were no wild-born samples). (c) Percent seroreactivity in Eurasian felids (excluding lynx, bay cat, rusty spotted cat, and Chinese desert cat, for
which there were no wild-born samples).
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cats in particular, a considerable number of free-ranging
striped hyenas (19), spotted hyenas (51), and Iberian lynx (48)
were obtained for this study.
A total of 1,195 animals from 36 species were screened with
three antigens (FIV-Fca, FIV-Ple, and FIV-Pco). The three-
antigen screening was clearly more sensitive at detecting spe-
cies-specific virus (i.e., FIV-Ple in lions and FIV-Pco in pu-
mas), but it also resulted in up to 20% more indeterminate
results in most populations. The general increase of indeter-
minate signals (i.e., low-level antibody responses to one or two
FIG. 4. (a) Phylogenetic tree for FIV pol-RT nucleotide sequences (476 bp included in analysis). Shown here is the single ML tree. MP, ME
(neighbor joining based on the Tajima Nei algorithm for distance measure), and Bayesian trees gave similar topologies. Bootstrap values and
posterior probabilities are included at all nodes with bootstrap support (ML/ME/MP/Bayesian). Taxa are designated with the species code followed
by the source animal identification number. Sequences downloaded from GenBank for comparison are boxed; all other sequences are novel. A
single asterisk indicates a sequence obtained from a captive but wild-born animal; a double asterisk indicates a sequence obtained from a
captive-born animal. All other novel sequences are from free-ranging animals. Analysis used empirical base frequencies, an estimated shape
parameter of 0.6618, and an estimated substitution matrix as follows: A/C  2.0642, A/G  7.2581, A/T  1.4798, C/G  4.0169, C/T  14.0129,
and an estimated proportion of invariant sites of 0.1525. (b) Alignments of the predicted amino acid translation products of FIV sequences from
individual animals. Single-letter amino acid codes are used. Only variable amino acids are included. Dashes indicate missing data or a gap
introduced to optimize the alignment. Sites that distinguish multiple FIV strains from each other are shown as black letters on a grey background,
and species-specific differences are shown as white letters on a black background. (c) Phylogenetic tree for FIV pol-RT amino acid sequences (159
amino acid residues were included in the analysis). Shown here is the single maximum likelihood tree with maximum likelihood bootstraps from
1,000 replicates. Abbreviations are as for panel a.
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antigens, but negative responses to the others) in the three-
antigen Western blot screening may represent the higher sen-
sitivity of this screening or may merely reflect more opportu-
nity for nonspecific cross-reactivity. Most (79%) of the samples
classified as indeterminate were PCR negative, suggesting that
many weak signals were false positives. Alternatively, some
individuals may harbor a strain of FIV that is both antigenically
(resulting in weak Western blot signals) and genetically (re-
sulting in failure of primer binding) divergent from the viruses
used in these screenings. The complete lack of indeterminate
signals from some species despite large sample sizes (for ex-
ample, sera from 0/202 Namibian cheetahs, 0/66 Asian leop-
ards, and 0/81 leopard cats were seroreactive) implies that the
higher levels of indeterminates in other species (for example,
sera from 24/212 tigers and 6/44 bobcats were indeterminately
seroreactive) are significant and suggestive of actual FIV ex-
posure.
FIV infection was confirmed via PCR in 69% (n  273) of
the Western blot-positive animals and 21% (n  108) of West-
ern blot indeterminates. PCR verification of FIV infection in
free-ranging animals has been obtained for cheetahs, leopards,
and spotted hyenas as well as lions and pumas, whose FIV
status and phylogeny is well documented (5, 8, 10, 14, 24, 35).
Species-specific FIV strains also were amplified from wild-born
jaguarundis, ocelots, and Pallas’ cats, suggesting that these
strains circulate in free-ranging populations. Western blot pos-
itives in free-ranging animals also indicate that FIV is endemic
in these three species as well as in the spotted hyena and
margay.
Western blot positives from wild-born animals suggest that
additional species-specific viruses may exist in free-ranging
populations of Geoffroy’s cats, jaguars, margays, and tigrinas,
pending Western blot and PCR verification from free-ranging
individuals. Western blot-indeterminate results from free-
ranging and/or wild-born individuals (without PCR verifica-
tion) were found in an additional eight species, namely, the
bobcat, Asian golden cat, clouded leopard, jungle cat, Iberian
lynx, marbled cat, and tiger.
Phylogenetic analysis indicates that the lentiviruses infecting
all feline species and the spotted hyena are related, suggesting
either an ancient introduction of this virus to the Felidae and
Hyaenidae (i.e., prior to the Felidae/Hyaenidae split) or cross-
species transmissions, some of which must have occurred be-
fore the end of the last glaciations, around 10,000 years ago,
when lions and cheetahs disappeared from the new world. As
with SIV (27, 31), the FIV phylogeny does not exactly mirror
that of its feline host species, and some feline species (puma
and lion) harbor more than one distinct FIV type. In fact, there
is no indication in the FIV phylogeny of any concurrent evo-
lution between virus and host, as is seen in some branches of
the SIV/HIV phylogeny (4, 15), nor is there a strict geographic
distribution of viral strains, as would be expected with more
recent introductions. However, there is some geographic par-
titioning reflected in the amino acid phylogeny, including an
old world/new world split (Fig. 4c). In addition, the strains
infecting cheetah (FIV-Aju) and leopard (FIV-Ppa) are closely
related, perhaps reflecting the similar ecological niche occu-
pied by these two species. There is no obvious explanation for
the grouping of Pallas’ cat FIV (FIV-Oma) with that of chee-
tah and leopard. FIV-Oma has now been confirmed for free-
ranging Pallas’ cats in Mongolia (M. Brown, et al., unpublished
results), indicating that this strain does not reflect interspecies
transmission in captivity.
While only results from animals living in the wild (free-
ranging) can indicate the prevalence and potential threat of
FIV to wild populations, the spread of FIV in captive animals
is interesting. These animals are in unnatural proximity to a
variety of related species, including domestic cats, and might
acquire a form of FIV that they would not normally encounter
or contract in a natural setting. For example, a captive puma in
an Argentine zoo has been shown to harbor domestic cat FIV,
although the FIV strains found in wild pumas (FIV-Pco) are
quite distant from FIV-Fca (10). Here, we also report a captive
snow leopard and a captive-born tiger, both infected with a
FIV-Ple-1 clade A sequence similar to that seen in both free-
ranging and captive lions. No FIV has been found in either of
these species in the wild (wild-born or free-ranging tigers, n 
34; wild-born snow leopards, n  3) (Table 2); however, they
are clearly susceptible to cross-species transmission under cer-
tain circumstances. Cross-species transmission has also been
observed in the wild, where a population of leopard cats be-
came infected with FIV-Fca presumably obtained following
exposure to infected domestic cats (20).
Given that only nine species have been shown to harbor
species-specific virus in the wild, the potential for new and
perhaps devastating outbreaks in naı¨ve species is of great con-
cern. This danger is heightened by the encroachment of hu-
mans and their domestic animals into the habitat of most wild
felines. In addition, the ever-decreasing habitat of most feline
species may serve to increase inter- and intraspecies aggres-
sion, further facilitating the spread and cross-species transmis-
sion of infectious disease. Finally, decreased genetic diversity
in most wild populations reduces the ability of these species to
adapt to new viral outbreaks (25, 30), decreasing the likelihood
that naı¨ve species will be able to undergo viral/host coevolution
rendering their strain of FIV relatively benign, as has presum-
ably occurred with the lion and the puma in the past (9).
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